ES2157148A1 - Nuevas piperidinas 4-sustituidas. - Google Patents

Nuevas piperidinas 4-sustituidas.

Info

Publication number
ES2157148A1
ES2157148A1 ES009802420A ES9802420A ES2157148A1 ES 2157148 A1 ES2157148 A1 ES 2157148A1 ES 009802420 A ES009802420 A ES 009802420A ES 9802420 A ES9802420 A ES 9802420A ES 2157148 A1 ES2157148 A1 ES 2157148A1
Authority
ES
Spain
Prior art keywords
serotonin
noradrenaline reuptake
substituted
aryloxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009802420A
Other languages
English (en)
Other versions
ES2157148B1 (es
Inventor
Venero Aurelio Orjales
Avello Antonio Toledo
Duran Carmen Pumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority to ES009802420A priority Critical patent/ES2157148B1/es
Priority to CA002288533A priority patent/CA2288533C/en
Priority to HU9904086A priority patent/HU227558B1/hu
Priority to ARP990105657A priority patent/AR028805A1/es
Priority to AT99500208T priority patent/ATE422199T1/de
Priority to DE69940378T priority patent/DE69940378D1/de
Priority to DK99500208T priority patent/DK1002794T3/da
Priority to CZ19993995A priority patent/CZ296053B6/cs
Priority to PT99500208T priority patent/PT1002794E/pt
Priority to IL13286299A priority patent/IL132862A0/xx
Priority to ES99500208T priority patent/ES2323742T3/es
Priority to EP99500208A priority patent/EP1002794B1/en
Priority to AU59366/99A priority patent/AU757177B2/en
Priority to HR990354A priority patent/HRP990354B1/xx
Priority to NO19995643A priority patent/NO314401B1/no
Priority to PL336607A priority patent/PL196329B1/pl
Priority to RU99124412/04A priority patent/RU2232753C2/ru
Priority to BRPI9905634-8A priority patent/BR9905634B1/pt
Priority to TR1999/02839A priority patent/TR199902839A2/xx
Priority to KR1019990051053A priority patent/KR100646675B1/ko
Priority to JP32888599A priority patent/JP4667552B2/ja
Priority to US09/824,189 priority patent/US6518284B2/en
Publication of ES2157148A1 publication Critical patent/ES2157148A1/es
Application granted granted Critical
Publication of ES2157148B1 publication Critical patent/ES2157148B1/es
Priority to CY20091100388T priority patent/CY1108955T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevas piperidinas 4-sustituidas. Se describen nuevas piperidinas-4 sustituidas de fórmula general (I), donde R{sub, 1}, y R{sub, 2} son radicales arilo, sustituidos o sin sustituir, y que son obtenidas como mezclas racémicas y como enantiómeros puros. **FORMULA** . Estos compuestos, y sus sales farmacéuticamente aceptables, inhiben la recaptación de serotonina y/o noradrenalina, siendo de utilidad como antidepresivos. Otras posibles aplicaciones terapéuticas de estos compuestos son el tratamiento de la bulimia nerviosa, los desórdenes obsesivo-compulsivos, la adicción al alcohol, la ansiedad, el pánico, el dolor, el síndrome premenstrual y la fobia social, así como la profilaxis de la migraña.
ES009802420A 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas. Expired - Fee Related ES2157148B1 (es)

Priority Applications (23)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.
CA002288533A CA2288533C (en) 1998-11-18 1999-11-04 New 4-substituted piperidines
HU9904086A HU227558B1 (en) 1998-11-18 1999-11-08 4-substituted piperidine derivatives and pharmaceutical compositions containing them
ARP990105657A AR028805A1 (es) 1998-11-18 1999-11-09 Nuevas piperidinas 4-sustituidas, asi como sus sales farmaceuticas con acidos inoranicos y organicos, obtenidas como mezclas racemicas y como enantiomeros puros, mezclados con excipientes para administracion oral, parental y topica
AT99500208T ATE422199T1 (de) 1998-11-18 1999-11-10 4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren
DK99500208T DK1002794T3 (da) 1998-11-18 1999-11-10 4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorer
CZ19993995A CZ296053B6 (cs) 1998-11-18 1999-11-10 4-Substituované piperidiny
PT99500208T PT1002794E (pt) 1998-11-18 1999-11-10 Derivados de 4-(aril)(aroloxi)metilpiperidina e sua utilização como inibidores da reabsorção da serotonina e/ou noradrenalina
IL13286299A IL132862A0 (en) 1998-11-18 1999-11-10 New 4-substituted piperidines
ES99500208T ES2323742T3 (es) 1998-11-18 1999-11-10 Derivados de 4-(aril)(ariloxi)metil piperidina y su uso como inhibidores de la recaptacion de serotonina y/o noradrenalina.
EP99500208A EP1002794B1 (en) 1998-11-18 1999-11-10 4-¬(Aryl)(aryloxy)methyl piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors
DE69940378T DE69940378D1 (de) 1998-11-18 1999-11-10 4-i(Aryl)(aryloxy)methyl piperidinderivate und ihre Verwendung als Serotonin und/oder Noradrenalin Reuptake Inhibitoren
AU59366/99A AU757177B2 (en) 1998-11-18 1999-11-11 New 4-substituted piperidines
HR990354A HRP990354B1 (en) 1998-11-18 1999-11-16 New 4-substituted piperidines
KR1019990051053A KR100646675B1 (ko) 1998-11-18 1999-11-17 신규의 4-치환된 피페리딘
RU99124412/04A RU2232753C2 (ru) 1998-11-18 1999-11-17 4-замещенные пиперидины, фармацевтическая композиция на их основе и способ лечения заболеваний центральной нервной системы
BRPI9905634-8A BR9905634B1 (pt) 1998-11-18 1999-11-17 piperidinas 4-substituìdas.
TR1999/02839A TR199902839A2 (xx) 1998-11-18 1999-11-17 Yeni 4-ikameli piperidinler.
NO19995643A NO314401B1 (no) 1998-11-18 1999-11-17 Nye, 4-substituerte piperidiner, farmasöytisk preparat inneholdende disse og anvendelse av dem for fremstilling av et medikament
PL336607A PL196329B1 (pl) 1998-11-18 1999-11-17 4-podstawione piperydyny, kompozycja farmaceutyczna zawierająca takie związki oraz zastosowanie
JP32888599A JP4667552B2 (ja) 1998-11-18 1999-11-18 新規な４−置換ピペリジン
US09/824,189 US6518284B2 (en) 1998-11-18 2001-04-02 4-substituted piperidines
CY20091100388T CY1108955T1 (el) 1998-11-18 2009-04-02 Παραγωγα 4-(αρυλ)-(αρυλοξυ)μεθυλοπιπεριδινης και η χρηση τους ως αναστολεις επαναπροσληψης σεροτονινης και/ή νοραδρεναλινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.

Publications (2)

Publication Number Publication Date
ES2157148A1 true ES2157148A1 (es) 2001-08-01
ES2157148B1 ES2157148B1 (es) 2002-03-01

Family

ID=8305832

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009802420A Expired - Fee Related ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.
ES99500208T Expired - Lifetime ES2323742T3 (es) 1998-11-18 1999-11-10 Derivados de 4-(aril)(ariloxi)metil piperidina y su uso como inhibidores de la recaptacion de serotonina y/o noradrenalina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99500208T Expired - Lifetime ES2323742T3 (es) 1998-11-18 1999-11-10 Derivados de 4-(aril)(ariloxi)metil piperidina y su uso como inhibidores de la recaptacion de serotonina y/o noradrenalina.

Country Status (21)

Country Link
EP (1) EP1002794B1 (es)
JP (1) JP4667552B2 (es)
KR (1) KR100646675B1 (es)
AR (1) AR028805A1 (es)
AT (1) ATE422199T1 (es)
AU (1) AU757177B2 (es)
BR (1) BR9905634B1 (es)
CA (1) CA2288533C (es)
CY (1) CY1108955T1 (es)
CZ (1) CZ296053B6 (es)
DE (1) DE69940378D1 (es)
DK (1) DK1002794T3 (es)
ES (2) ES2157148B1 (es)
HR (1) HRP990354B1 (es)
HU (1) HU227558B1 (es)
IL (1) IL132862A0 (es)
NO (1) NO314401B1 (es)
PL (1) PL196329B1 (es)
PT (1) PT1002794E (es)
RU (1) RU2232753C2 (es)
TR (1) TR199902839A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101443A1 (en) * 2002-05-30 2003-12-11 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
UA77536C2 (en) * 2002-07-03 2006-12-15 Lundbeck & Co As H Secondary aminoaniline piperidines as mch1 antagonists and their use
EP1735302B1 (en) 2004-02-27 2010-06-16 Eli Lilly And Company 4-amino-piperidine derivatives as monoamine uptake inhibitors
CN1968932A (zh) 2004-06-18 2007-05-23 惠氏公司 制备6－烷基－5－芳基磺酰基－二氢菲啶的方法
EP1854785A1 (en) * 2006-05-12 2007-11-14 Faes Farma, S.A. 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
CN101506164A (zh) * 2006-08-23 2009-08-12 辉瑞产品公司 哌啶衍生物
DK2358674T3 (da) * 2008-11-14 2013-04-08 Theravance Inc Fremgangsmåde til fremstilling af 4-[2-(2-fluorphenoxymethyl)phenyl]piperidinforbindelser
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
WO2011147780A1 (en) 2010-05-24 2011-12-01 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
EP2390248A1 (en) 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634437A (en) * 1968-06-10 1972-01-11 Ici Ltd 3-aryloxyalkylpiperidine derivatives
JPS61227565A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634437A (en) * 1968-06-10 1972-01-11 Ici Ltd 3-aryloxyalkylpiperidine derivatives
JPS61227565A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts, Vol. 106, no 25, 1987, abstract 213767 "Piperidine derivatives" & JP 61227565 A (EISAI) 09.10.1986 *
Chemical Abstracts, Vol. 124, no 25, 1996, abstract 343333 "Preparation of piperidinyl derivatives as antidepressants and anxiolytics" & JP 8040999 A (YAMANOUCHI PHARM) 13.02.1996 *
European Journal of Medicinal Chemistry. Chimica Therapeutica, Vol. 19, no 3, 1984, paginas 235-242. P. MELLONI et al. "Potential antidepressant agents". Pagina 238, compuesto 62. *

Also Published As

Publication number Publication date
BR9905634B1 (pt) 2012-09-04
EP1002794B1 (en) 2009-02-04
HU227558B1 (en) 2011-08-29
NO995643L (no) 2000-05-19
ATE422199T1 (de) 2009-02-15
IL132862A0 (en) 2001-03-19
EP1002794A1 (en) 2000-05-24
PT1002794E (pt) 2009-03-25
JP2000154176A (ja) 2000-06-06
AU757177B2 (en) 2003-02-06
CA2288533C (en) 2009-01-06
KR20000035525A (ko) 2000-06-26
HRP990354B1 (en) 2008-11-30
DE69940378D1 (de) 2009-03-19
PL196329B1 (pl) 2007-12-31
ES2157148B1 (es) 2002-03-01
CY1108955T1 (el) 2014-07-02
HUP9904086A2 (hu) 2000-11-28
CA2288533A1 (en) 2000-05-18
AR028805A1 (es) 2003-05-28
TR199902839A3 (tr) 2000-09-21
TR199902839A2 (xx) 2000-09-21
PL336607A1 (en) 2000-05-22
NO314401B1 (no) 2003-03-17
NO995643D0 (no) 1999-11-17
KR100646675B1 (ko) 2006-11-17
BR9905634A (pt) 2000-09-26
ES2323742T3 (es) 2009-07-23
RU2232753C2 (ru) 2004-07-20
DK1002794T3 (da) 2009-04-14
CZ399599A3 (cs) 2000-08-16
HUP9904086A3 (en) 2001-11-28
CZ296053B6 (cs) 2005-12-14
JP4667552B2 (ja) 2011-04-13
HRP990354A2 (en) 2000-06-30
HU9904086D0 (en) 2000-01-28
AU5936699A (en) 2000-05-25

Similar Documents

Publication Publication Date Title
ES2157148A1 (es) Nuevas piperidinas 4-sustituidas.
RU2489148C2 (ru) Ингибитор активации stat3/5
CA2389300A1 (en) 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
FI961776A (fi) Tiettyjä fuusioituneita pyrrolikarboksianilideja; uusi aivojen GABA-reseptoriligandien luokka
NZ533310A (en) Benzimidazoles useful as protein kinase inhibitors
NO20053242L (no) 4-substituerte benzimidazoler og deres anvendelse som inhibitorer av gastrisk sekresjon
CY1107199T1 (el) Καρβαμικες ενωσεις για χρηση στη προληψη ή τη θεραπευτικη αντιμετωπιση της διπολικης διαταραχης
NO980919L (no) 8-azabicyklo(3.2.1)okt-2-ene derivater, og deres anvendelse til fremstilling av et legemiddel
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
MX2012000577A (es) Compuestos de amino spiro apropiados para el tratamiento entre otras cosas de trastornos de sueño y adiccion a los farmacos.
PE20020063A1 (es) Bis-arilsulfonas como ligandos del receptor de 5-ht
AR048319A1 (es) Derivados de n-piperidina como moduladores de ccr3
JP2008525398A5 (es)
NO20055205L (no) 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer
KR950700903A (ko) 5-ht1 작용물질로서의 아실아미노인돌 유도체(acylaminoindole derivatives as 5-ht1 agonists)
PE20081160A1 (es) Arilsulfonil-pirrolidinas como inhibidores 5-ht6
HUP0302016A2 (hu) Piperazin és piperidinvegyületek, ezeket tartalmazó gyógyászati készítmények, eljárás elżállításukra és alkalmazásuk
AR036812A1 (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos para el tratamiento de enfermedades androgeno-dependientes
EA200600061A1 (ru) Бензамиды 4-(аминометил) пиперидина как 5нт-антагонисты
MY129304A (en) Carbamate compounds for use in preventing or treating bipolar disorder
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
PT1305082E (pt) Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
ATE392896T1 (de) 4-(2-phenyloxyphenyl)-piperidin- oder -1,2,3,6- tetrahydropyridin-derivate als serotonin- wiederaufnahme-hemmer
ATE446948T1 (de) Alpha-ketoamidderivativ, herstellungsverfahren und verwendung davon
RU99124412A (ru) Новые 4-замещенные пиперидины

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010801

Kind code of ref document: A1

Effective date: 20010801

GC2A Exploitation certificate registered application with search report

Effective date: 20070806

FD2A Announcement of lapse in spain

Effective date: 20180807